Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
5.83
+0.08 (1.39%)
At close: Jun 26, 2026, 4:00 PM EDT
5.85
+0.02 (0.34%)
After-hours: Jun 26, 2026, 7:52 PM EDT
Wave Life Sciences Market Cap
Wave Life Sciences has a market cap or net worth of $1.12 billion as of June 26, 2026. Its market cap has increased by 1.22% in one year.
Market Cap
1.12B
Enterprise Value
592.83M
1-Year Change
1.22%
Ranking
Category
Stock Price
$5.83
Market Cap Chart
Since November 11, 2015, Wave Life Sciences's market cap has increased from $334.93M to $1.12B, an increase of 234.90%. That is a compound annual growth rate of 12.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 1.12B | -63.94% |
| Dec 31, 2025 | 3.11B | 64.89% |
| Dec 31, 2024 | 1.89B | 213.58% |
| Dec 29, 2023 | 601.65M | -1.10% |
| Dec 30, 2022 | 608.37M | 229.32% |
| Dec 31, 2021 | 184.73M | -51.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MannKind | 1.28B |
| Seaport Therapeutics | 1.15B |
| EyePoint | 1.15B |
| Corvus Pharmaceuticals | 1.13B |
| Lexicon Pharmaceuticals | 1.13B |
| Cullinan Therapeutics | 1.13B |
| MeiraGTx Holdings | 1.12B |
| Xencor | 1.12B |